Volitionrx (VNRX) Total Liabilities (2018 - 2025)
Volitionrx filings provide 11 years of Total Liabilities readings, the most recent being $42.5 million for Q4 2025.
- On a quarterly basis, Total Liabilities rose 19.68% to $42.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $42.5 million, a 19.68% increase, with the full-year FY2025 number at $42.5 million, up 19.68% from a year prior.
- Total Liabilities hit $42.5 million in Q4 2025 for Volitionrx, roughly flat from $42.4 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $42.5 million in Q4 2025 to a low of -$31.2 million in Q1 2021.
- Median Total Liabilities over the past 5 years was $21.9 million (2022), compared with a mean of $24.4 million.
- Biggest five-year swings in Total Liabilities: tumbled 505.26% in 2021 and later skyrocketed 166.98% in 2022.
- Volitionrx's Total Liabilities stood at $9.8 million in 2021, then skyrocketed by 119.3% to $21.4 million in 2022, then skyrocketed by 71.15% to $36.7 million in 2023, then dropped by 3.15% to $35.5 million in 2024, then rose by 19.68% to $42.5 million in 2025.
- The last three reported values for Total Liabilities were $42.5 million (Q4 2025), $42.4 million (Q3 2025), and $41.8 million (Q2 2025) per Business Quant data.